COVID-19疫情中的癌症患者:专家关于如何调整当前实践的意见
本文为专家意见信,针对COVID-19大流行期间胸部肿瘤患者的诊疗实践提出调整建议。文章引用既往经验指出,癌症患者对病毒感染的不良结局易感性增高:流感使癌症患者因呼吸窘迫住院的风险增加4倍、死亡风险增加10倍。在武汉,SARS-CoV-2感染者中1%患有癌症,超过中国2015年癌症发病率的三倍;癌症患者中39%需要转入ICU(非癌症患者为8%),病情恶化更快(至严重事件13天 vs 43天)。化疗或手术前<1个月是重要危险因素(OR 5.34,p=0.0026)。专家建议通过减少住院时间和患者与医护人员的接触来调整实践,同时维持医疗质量。
要点
- 专家建议胸部肿瘤诊疗实践应通过减少住院时间和患者与医护人员的接触来适应COVID-19大流行,同时维持医疗质量。
- 既往经验显示流感使癌症患者因呼吸窘迫住院风险增加4倍、死亡风险增加10倍,中性粒细胞减少或淋巴细胞减少者风险尤其高。
- 武汉报告SARS-CoV-2感染者中1%患有癌症,超过中国2015年癌症发病率的三倍。
- 癌症患者中39%需要转入ICU(非癌症患者为8%),至严重事件时间13天 vs 43天,病情恶化更快。
- 化疗或手术前<1个月是重要危险因素(OR 5.34,p=0.0026)。
适用人群与场景
- 胸部肿瘤患者,尤其是接受化疗后出现中性粒细胞减少或淋巴细胞减少者。
研究设计与关键结果
- 本文为专家意见信,引用既往经验:流感使癌症患者因呼吸窘迫住院风险增加4倍、死亡风险增加10倍。
- 武汉报告SARS-CoV-2感染者中1%患有癌症,超过中国2015年癌症发病率的三倍。
- 癌症患者中39%需要转入ICU(非癌症患者为8%),至严重事件时间13天 vs 43天。
- 化疗或手术前<1个月是重要危险因素(OR 5.34,p=0.0026)。
证据类型、等级与局限
- 证据类型:专家意见(致编辑的信)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为胸部肿瘤诊疗实践可/应通过减少住院时间和患者与医护人员的接触来适应COVID-19大流行,同时维持医疗质量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Our current thoracic oncology practice could/should be adapted to the COVID-19 pandemic by reducing time in hospital and patient contacts with healthcare workers, whilst maintaining quality of care. This letter offers expert advice on how to do so. https://bit.ly/2JR2IoT
The susceptibility of cancer patients to the adverse outcomes of viral infections is well known from past experiences: influenza increases the risk of hospital admission with respiratory distress four times, and the risk of death 10 times, compared with patients without cancer [1]. This risk is particularly elevated in patients with neutropenia or lymphopenia, which is often the case in patients treated with chemotherapy. In Wuhan, China, 1% of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were reported to suffer from cancer, which is more than three times the incidence of cancer in the Chinese population in 2015 [2]. In addition, in 39% of cancer patients (compared with 8% of patients without cancer), transfer to the intensive care unit was necessary, with their illness deteriorating more rapidly (13 versus 43 days to severe event) [2]. Chemotherapy or surgery <1 month before was an important risk factor (OR 5.34, p=0.0026).
参考来源
- Raskin J, Lebeer M, De Bondt C, et al. Cancer in the time of COVID-19: expert opinion on how to adapt current practice. Eur Respir J. 2020. PMID: 32299866. doi:10.1183/13993003.00959-2020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。